MEDA INC
8-K/A, 1996-06-28
PHARMACEUTICAL PREPARATIONS
Previous: NATIONSBANK OF TEXAS N A, S-3/A, 1996-06-28
Next: NPS PHARMACEUTICALS INC, DEF 14A, 1996-06-28



               SECURITIES AND EXCHANGE COMMISSION

                     Washington, D.C. 20549

                            FORM 8-K

                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the 
                 Securities Exchange Act of 1934


Date of Report      5/21/96   


                           MEDA, INC.


     Delaware                 0-21816                  93-1116123
(State of Incorporation) (Commission File Number) (IRS Employer I.D. No.)


15845 SW 72nd Avenue, Building C, Portland, Oregon 97224


Registrant's telephone number:  (503) 639-1500 


                                1
<PAGE>
Change in Certifying Accountants

1.   Meda's former accountant, Deloitte & Touche, was dismissed on
     May 15, 1996.  Their letter concerning this report, as
     required by Item 304(a)(3) of Regulation S-K, will be filed as
     a supplement to this report.

2.   None of the former accountant's reports have contained an
     adverse opinion, but the May 31, 1995 report did raise a doubt
     about the Company's ability to continue as a going concern.  

3.   The decision to change accountants was approved by the Board
     of Directors.

4.   There have been no disagreements with the former accountant on
     any matter of accounting principles or practices, financial
     statement disclosure, or auditing scope or procedure.

5.   Meda's new accountant, Price Waterhouse, was engaged on May
     21, 1996.

6.   Prior to engagement, the only discussions Meda had with Price
     Waterhouse concerned fees, capabilities, scope of Meda
     operations, tax issues and possible future consulting
     projects.

7.   Nothing in Item 304(a)(2)(v)(A)-(D) of Regulation S-K is
     applicable to Meda or its former accountant's representation
     of Meda.  

8.   The new accountant has been given the opportunity to comment
     on this report, as required by Item 304(a)(2)(D) of Regulation
     S-K, and has indicated that it sees no need to comment.  

                                2
<PAGE>
SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.

(REGISTRANT)        MEDA, INC.
BY (SIGNATURE)      /s/ James N. Weider
(NAME AND TITLE)    James N. Weider, Vice President Finance 
                      and CFO
(DATE)              May 21, 1996                  
                                   

                                3
<PAGE>

DELOITTE & TOUCHE LLP
3900 US Bancorp Tower
111 SW Fifth Avenue
Portland, Oregon 97204-3698
Telephone:  (503) 222-1341
Facsimile:  (503) 224-2172




June 19, 1996


Securities and Exchange Commission
Mail Stop 9-5
450 5th Street, N.W.
Washington, D.C. 20549

Dear Sirs/Madams:

We have read and agree with the comments in Form 8-K of Meda, Inc.
dated May 21, 1996, which was presented to us on June 14, 1996.

Very truly yours,


/s/ Deloitte & Touche LLP


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission